Abzena Launches EpiScreen® 2.0, a Next Generation Immunogenicity Tool for De-Risking the Development of Complex Biologics and Bioconjugates ...Middle East

CAMBRIDGE, England, April 25, 2024 /PRNewswire/ -- Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, has announced the launch of its enhanced bioassay platform EpiScreen® 2.0, a comprehensive suite of assays that predict and evaluate potential risks...

Hence then, the article about abzena launches episcreen 2 0 a next generation immunogenicity tool for de risking the development of complex biologics and bioconjugates was published today ( Thursday 25/04/2024 - 09:44 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Abzena Launches EpiScreen® 2.0, a Next Generation Immunogenicity Tool for De-Risking the Development of Complex Biologics and Bioconjugates )

Also on site :

• Ryan Gosling Says Harrison Ford’s “Not Like Us” After Seeing Him “House Half a Bottle of Advil as a Joke”
• Macy’s 'Sparkly' $34 Crystal Stud Earrings Look 'High-End' and They 'Go With Everything'
• Sundance-Winning Iranian Filmmaker’s ‘Rainy Dreams’ Explores Children’s Nightmares Amid Displacement at Hong Kong Financing Forum